StockData
TransMedics Group, Inc. logo

TransMedics Group, Inc. (TMDX) stock

TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3034% below fair value
$85.25−8.77 (-9.33%)

Close on Nov 20, 2026Market cap $2.96BP/E 22.1Yield 0.00%

TransMedics gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

TransMedics's gross profit for the twelve months ending Jun 30, 2026 was $392.35M, up 23.5% year over year. For fiscal 2025 it was $362.81M, up 38.4% from the year before. The highest annual figure on record is $362.81M in fiscal 2025.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$362.81M+38.4%
FY2024Dec 31, 2024$262.08M+70.1%
FY2023Dec 31, 2023$154.09M+136.1%
FY2022Dec 31, 2022$65.27M+208.5%
FY2021Dec 31, 2021$21.16M+27.2%
FY2020Dec 31, 2020$16.64M+20.0%
FY2019Dec 28, 2019$13.86M+141.8%
FY2018Dec 29, 2018$5.73M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$113.20M+17.2%
Q1 FY2026Mar 31, 2026$101.16M+14.7%
Q4 FY2025Dec 31, 2025$93.41M+29.7%
Q3 FY2025Sep 30, 2025$84.58M+39.0%
Q2 FY2025Jun 30, 2025$96.59M+39.5%
Q1 FY2025Mar 31, 2025$88.23M+47.1%
Q4 FY2024Dec 31, 2024$72.01M+50.3%
Q3 FY2024Sep 30, 2024$60.85M+49.6%
Q2 FY2024Jun 30, 2024$69.26M+88.5%
Q1 FY2024Mar 31, 2024$59.96M+108.4%
Q4 FY2023Dec 31, 2023$47.92M+131.5%
Q3 FY2023Sep 30, 2023$40.66M+124.5%
Q2 FY2023Jun 30, 2023$36.74M+156.0%
Q1 FY2023Mar 31, 2023$28.77M+137.7%
Q4 FY2022Dec 31, 2022$20.70M+196.3%
Q3 FY2022Sep 30, 2022$18.12M+380.1%
Q2 FY2022Jun 30, 2022$14.35M+156.8%
Q1 FY2022Mar 31, 2022$12.10M+151.6%
Q4 FY2021Dec 31, 2021$6.99M+44.7%
Q3 FY2021Sep 30, 2021$3.77M-25.1%
Q2 FY2021Jun 30, 2021$5.59M+192.8%
Q1 FY2021Mar 31, 2021$4.81M-1.0%
Q4 FY2020Dec 31, 2020$4.83M+29.1%
Q3 FY2020Sep 30, 2020$5.04M+19.5%
Q2 FY2020Jun 30, 2020$1.91M-42.7%
Q1 FY2020Mar 31, 2020$4.86M+88.9%
Q4 FY2019Dec 28, 2019$3.74M+149.6%
Q3 FY2019Sep 28, 2019$4.22M+97.7%
Q2 FY2019Jun 29, 2019$3.33M+182.7%
Q1 FY2019Mar 30, 2019$2.57M+178.5%
Q4 FY2018Dec 29, 2018$1.50M–
Q3 FY2018Sep 29, 2018$2.13M–
Q2 FY2018Jun 30, 2018$1.18M–
Q1 FY2018Mar 31, 2018$924.00K–

More TransMedics figures

See a number that looks wrong?